PI3Kα-IN-33
PI3Kα-IN-33 is an orally active and selective PI3Kα inhibitor with an IC50 of 9.9 nM. PI3Kα-IN-33 blocks the PI3K/Akt/mTOR signaling pathway. PI3Kα-IN-33 induces apoptosis and triggers G2/M-phase arrest via Cyclin B1 and CDK1 downregulation. PI3Kα-IN-33 can be used for the research of colorectal cancer.
For research use only. We do not sell to patients.
- Formula: C20H19N5O3
- Molecular Weight:377.40
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Biological Activity
Description
IC50 & Target
[1]|
PI3Kα 9.9 nM (IC50) |
CDK1/cyclinB1 |
In Vitro
PI3Kα-IN-33 (Compound 8b) forms a stable, high-affinity complex with PI3Kα[1].
PI3Kα-IN-33 (48 h) potently inhibits proliferation of multiple cancer cell lines, with the highest activity against HCT-116 colorectal cancer cells (IC50 = 0.53 μM), and has reduced cytotoxicity toward normal HEK293 cells (IC50 = 7.42 μM)[1].
PI3Kα-IN-33 (2.0 μM; 12 h) effectively inhibits the migratory ability of HCT-116 colorectal cancer cells[1].
PI3Kα-IN-33 (0.5-2.0 μM; 2 weeks) inhibits colony formation of HCT-116 colorectal cancer cells in a concentration-dependent manner[1].
PI3Kα-IN-33 (0.5-2.0 μM; 48 h) induces selective G2/M-phase arrest in HCT-116 colorectal cancer cells at concentrations of 0.5, 1.0, and 2.0 μM[1].
PI3Kα-IN-33 (0.5-2.0 μM; 48 h) at concentrations of 0.5, 1.0, and 2.0 μM causes concentration-dependent downregulation of Cyclin B1 and CDK1 in HCT-116 colorectal cancer cells[1].
PI3Kα-IN-33(0.5-2.0 μM; 48 h) at concentrations of 0.5, 1.0, and 2.0 μM triggers concentration-dependent activation of the mitochondrial apoptotic pathway and induction of DNA double-strand breaks in HCT-116 colorectal cancer cells[1].
PI3Kα-IN-33 (0.5-2.0 μM; 24 h) triggers concentration-dependent mitochondrial membrane potential depolarization in HCT-116 colorectal cancer cells[1].
PI3Kα-IN-33 (0.5-2.0 μM; 48 h) induces concentration-dependent apoptosis in HCT-116 colorectal cancer cells, with 33.3% total apoptosis at 2.0 μM[1].
PI3Kα-IN-33 (1.0-5.0 μM; 48 h) concentration-dependently inhibits the PI3K/Akt/mTOR signaling pathway in HCT-116 colorectal cancer cells[1].
PI3Kα-IN-33 blocks the PI3K-Akt-mTOR axis in HCT-116 colorectal cancer cells, driving transcriptional reprogramming of oncogenic and metabolic pathways including suppressed glycolysis and MTORC1 signaling[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only. Further protocols information, click here.
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:2.0 μM
-
Incubation Time:12 h
-
Result:Significantly reduced HCT-116 cell migration compared to the control, with a migration inhibition rate of approximately 75%.
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:0.5 μM; 1 μM; 2.0 μM
-
Incubation Time:2 weeks
-
Result:Inhibited HCT-116 colony formation in a concentration-dependent manner.
At 2.0 μM, the number of surviving colonies was reduced to approximately 1 × 103, showing a strong inhibitory effect.
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:0.5 μM; 1 μM; 2.0 μM
-
Incubation Time:48 h
-
Result:Selectively induced G2/M-phase arrest in HCT-116 cells, increasing the G2/M population from 14.2% (control) to 23.4% at 0.5 μM, while G0/G1 and S-phase fractions remained largely unchanged.
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:0.5 μM; 1 μM; 2.0 μM
-
Incubation Time:48 h
-
Result:Induced concentration-dependent downregulation of Cyclin B1 and CDK1 protein levels, supporting blockade of the G2/M transition.\nInduced concentration-dependent increases in the Bax/Bcl-2 ratio, upregulation of cleaved caspase-9 and cleaved caspase-3, and increased levels of γ-H2AX (a marker of DNA double-strand breaks).
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:0.5 μM; 1 μM; 2.0 μM
-
Incubation Time:48 h
-
Result:Induced apoptosis in a concentration-dependent manner, with total apoptotic cell percentages increasing to 21.66% (0.5 μM), 29.6% (1.0 μM), and 33.3% (2.0 μM).
-
Cell Line:HCT-116 colorectal cancer cells
-
Concentration:1 μM; 2 μM; 5 μM
-
Incubation Time:48 h
-
Result:Inhibited phosphorylation of PI3K, Akt, p70S6K, and 4EBP1 in a concentration-dependent manner.
At 2.0 μM, it exhibited strong inhibitory effects on p-PI3K, p-p70S6K, and p-Akt phosphorylation.
Parmacokinetics
In Vivo
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Sprague-Dawley (SD) rats (male and female)[1]
-
Dosage:5 mg/kg; 10 mg/kg
-
Administration:i.v. or i.g.; single dose
-
Result:Exhibited an AUC0-t of 23078 μg/L·h, an AUC0-∞ of 23119 μg/L·h, a MRT0-t of 2.41 h, a MRT0-∞ of 2.45 h, a t1/2 of 2.95 h, a CL of 0.22 L/h·kg, a Vd of 0.94 L/kg, and a Cmax of 13600.39 μg/L at 5 mg/kg i.v.
Exhibited an AUC0-t of 16453 μg/L·h, an AUC0-∞ of 16481 μg/L·h, a MRT0-t of 5.89 h, a MRT0-∞ of 5.92 h, a t1/2 of 2.31 h, a CL of 0.61 L/h·kg, a Vd of 2.04 L/kg, a Cmax of 2666.62 μg/L, a tmax of 1 h, and a F of 35.6% at 10 mg/kg i.g.
Chemical Information
-
Molecular Weight 377.40
-
Formula C20H19N5O3
-
SMILES
NC1=NC2=CC(C3=CC=C(N=CC(N4CCOCC4CO)=N5)C5=C3)=CC=C2O1
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Protocols
-
Apoptosis
Apoptosis, also called programmed cell death, is generally characterized by distinct morphological characteristics.
-
TUNEL staining for apoptotic DNA fragmentation
TUNEL staining detects DNA strand breaks by using terminal deoxynucleotidyl transferase to add labeled nucleotides to exposed 3′-OH DNA termini, generating either microscopic staining in fixed cells or tissue sections, or fluorescence/cytometric signal in cell suspensions. TUNEL positivity reflects DNA fragmentation but should not be interpreted alone as definitive apoptosis, because TUNEL can also label necrotic, autolytic, mechanically damaged, or DNA-repair-associated DNA breaks.
-
Cell Cytotoxicity Assay
Cytotoxicity assays are usually based on the assessment of cell membrane damage, which can also be indirectly detected by measuring cell viability. Detection methods include MTT assay, CKK-8 assay, LDH assay and ATP assay, etc.
-
Flow cytometric DNA-content cell-cycle staining
Flow cytometric DNA-content cell-cycle staining measures the fluorescence intensity of DNA-bound fluorochromes in single cells or nuclei to estimate DNA content distributions, allowing assignment of populations to G0/G1, S, and G2/M phases by DNA histogram deconvolution. Propidium iodide (PI) intercalates into DNA, and PI fluorescence is proportional to cellular DNA content when staining is performed under conditions that make DNA accessible and minimize non-DNA signal. Cells with G2/M DNA content are expected to show approximately twice the fluorescence intensity of G0/G1 cells, while S-phase cells occupy intermediate fluorescence values. PI-based DNA-content analysis can also detect cells with fractional DNA content, often reported as sub-G1, when DNA fragmentation and extraction during staining reduce retained DNA signal in apoptotic cells. DAPI is an alternative DNA fluorochrome for univariate DNA-content analysis, while bivariate approaches combining DNA content with proliferation
-
Annexin V plus membrane-impermeant dye apoptosis staining
Annexin V-based apoptosis assays rely on the detection of phosphatidylserine (PS) externalization from the inner leaflet of the plasma membrane to the outer leaflet, an early biochemical hallmark of apoptosis. Fluorescently labeled Annexin V binds PS in a calcium-dependent manner, enabling identification of early apoptotic cells by flow cytometry or fluorescence microscopy. When combined with a membrane-impermeant DNA-binding dye (e. g. , propidium iodide), this approach allows discrimination between viable (Annexin V−/dye−), early apoptotic (Annexin V+/dye−), and late apoptotic or necrotic (Annexin V+/dye+) cell populations by assessing membrane integrity and PS exposure.
-
Apoptosis Solutions
Apoptosis is a regulated, generally non-lytic cell-death pathway that removes unwanted, damaged, infected, or abnormal cells through coordinated morphological changes, caspase activation, DNA fragmentation, and membrane remodeling. The intrinsic apoptosis pathway is controlled mainly by mitochondrial outer membrane permeabilization, BCL-2 family proteins, cytochrome c release, apoptosome formation, caspase-9 activation, and downstream executioner caspase-3/7 activation. The extrinsic apoptosis pathway is initiated by death receptors such as Fas, TNFR, and TRAIL receptors, which recruit adaptor proteins and activate caspase-8 before engaging executioner caspases or mitochondrial amplification through BID cleavage. Apoptosis is linked to many phenotypes, including cancer cell killing, tissue homeostasis, immune regulation, neurodegeneration, infection response, and treatment-induced cytotoxicity; unresolved questions include how apoptosis interacts with necroptosis, pyroptosis, ferroptos
-
Protocol for Cell Cycle
Cell-cycle analysis by flow cytometry measures DNA content in single cells to estimate the fraction of cells in G0/G1, S, and G2/M phases. Propidium iodide intercalates into DNA, and after RNA removal with RNase, fluorescence intensity reflects cellular DNA content: 2N cells are assigned to G0/G1, cells between 2N and 4N to S phase, and 4N cells to G2/M. DNA-content analysis alone cannot reliably separate G0 from G1 or G2 from M. Ki-67 can distinguish quiescent G0 cells from cycling cells, EdU or BrdU incorporation marks active DNA synthesis in S phase, and phospho-histone H3 staining identifies mitotic cells within the 4N population.
Purity & Documentation
References
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)